Chen Xiang Yang
Chief Tech/Sci/R&D Officer presso INNOCARE PHARMA LIMITED
Profilo
Attualmente, Chen Xiang Yang occupa la posizione di Chief Technology Officer per InnoCare Pharma Ltd. In precedenza è stato direttore della Pfizer Inc. e direttore esecutivo della chimica medicinale alla BioDuro (Beijing) Co. Ha conseguito una laurea presso l'Università di Pechino e un dottorato presso la Emory University.
Posizioni attive di Chen Xiang Yang
Società | Posizione | Inizio |
---|---|---|
INNOCARE PHARMA LIMITED | Chief Tech/Sci/R&D Officer | 01/10/2019 |
Precedenti posizioni note di Chen Xiang Yang
Società | Posizione | Fine |
---|---|---|
BioDuro (Beijing) Co., Ltd.
BioDuro (Beijing) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services BioDuro (Beijing) Co., Ltd. operates as a integrated drug discovery outsourcing company that provides integrated research and development services to biopharmaceutical clients. Its services range from medicinal chemistry to discovery biology, pharmacology, drug metabolism and pharmacokinetics (DMPK) and drug safety evaluation. The company was founded in 2006 and is headquartered in Beijing, China. | Corporate Officer/Principal | 01/09/2015 |
PFIZER, INC. | Corporate Officer/Principal | 01/03/2010 |
Formazione di Chen Xiang Yang
Emory University | Doctorate Degree |
Peking University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
PFIZER, INC. | Health Technology |
INNOCARE PHARMA LIMITED | Health Technology |
Aziende private | 1 |
---|---|
BioDuro (Beijing) Co., Ltd.
BioDuro (Beijing) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services BioDuro (Beijing) Co., Ltd. operates as a integrated drug discovery outsourcing company that provides integrated research and development services to biopharmaceutical clients. Its services range from medicinal chemistry to discovery biology, pharmacology, drug metabolism and pharmacokinetics (DMPK) and drug safety evaluation. The company was founded in 2006 and is headquartered in Beijing, China. | Commercial Services |
- Borsa valori
- Insiders
- Chen Xiang Yang